Mark Belletrutti

729 total citations
30 papers, 359 citations indexed

About

Mark Belletrutti is a scholar working on Hematology, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Mark Belletrutti has authored 30 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Surgery. Recurrent topics in Mark Belletrutti's work include Hemophilia Treatment and Research (7 papers), Platelet Disorders and Treatments (6 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Mark Belletrutti is often cited by papers focused on Hemophilia Treatment and Research (7 papers), Platelet Disorders and Treatments (6 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Mark Belletrutti collaborates with scholars based in Canada, United States and United Kingdom. Mark Belletrutti's co-authors include Mary Bauman, M. Patricia Massicotte, David Nicholas, Laszlo Bajzar, Laura Beaune, Maru Barrera, Stefan Kuhle, Maximilian T. Lobmeyer, Lesley Mitchell and Adam Rapoport and has published in prestigious journals such as Blood, Thrombosis and Haemostasis and Canadian Medical Association Journal.

In The Last Decade

Mark Belletrutti

28 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Belletrutti Canada 12 163 71 67 62 52 30 359
Irene Cherrick United States 12 314 1.9× 298 4.2× 162 2.4× 66 1.1× 140 2.7× 18 710
Eva‐Marie Jacobsen Norway 13 212 1.3× 82 1.2× 74 1.1× 46 0.7× 42 0.8× 20 496
Dana Schwartz United States 11 41 0.3× 19 0.3× 60 0.9× 23 0.4× 136 2.6× 18 310
Sonia Whyte United Kingdom 12 113 0.7× 29 0.4× 361 5.4× 79 1.3× 85 1.6× 26 903
Kerry Morrone United States 11 161 1.0× 16 0.2× 56 0.8× 9 0.1× 28 0.5× 33 372
Susan E. Creary United States 13 443 2.7× 56 0.8× 214 3.2× 12 0.2× 19 0.4× 67 745
Ruta Tuckuviene Denmark 11 247 1.5× 191 2.7× 141 2.1× 56 0.9× 36 0.7× 29 452
A. L. Svendsen Denmark 8 121 0.7× 103 1.5× 164 2.4× 83 1.3× 85 1.6× 10 636
Jennifer B. Soep United States 10 154 0.9× 23 0.3× 8 0.1× 36 0.6× 81 1.6× 19 435
Jeffrey D. Hord United States 15 198 1.2× 9 0.1× 201 3.0× 5 0.1× 32 0.6× 34 568

Countries citing papers authored by Mark Belletrutti

Since Specialization
Citations

This map shows the geographic impact of Mark Belletrutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Belletrutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Belletrutti more than expected).

Fields of papers citing papers by Mark Belletrutti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Belletrutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Belletrutti. The network helps show where Mark Belletrutti may publish in the future.

Co-authorship network of co-authors of Mark Belletrutti

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Belletrutti. A scholar is included among the top collaborators of Mark Belletrutti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Belletrutti. Mark Belletrutti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Belletrutti, Mark, et al.. (2023). Management of children with hemophilia A on emicizumab who need surgery. Frontiers in Pediatrics. 11. 1155853–1155853. 3 indexed citations
3.
Young, Nancy L., Victor S. Blanchette, Robert J. Klaassen, et al.. (2021). Measuring the impact of hemophilia on families: Development of the Hemophilia Family Impact Tool (H‐FIT). Research and Practice in Thrombosis and Haemostasis. 5(4). e12519–e12519. 3 indexed citations
4.
Young, Nancy L., Koyo Usuba, Mark Belletrutti, et al.. (2021). Quality of life in adolescents with heavy menstrual bleeding: Validation of the Adolescent Menstrual Bleeding Questionnaire (aMBQ). Research and Practice in Thrombosis and Haemostasis. 5(7). e12615–e12615. 18 indexed citations
5.
Nicholas, David, et al.. (2020). Engaging Fathers in Pediatric Palliative Care Research. Journal of Social Work in End-of-Life & Palliative Care. 16(1). 42–56. 14 indexed citations
6.
Nicholas, David, Mark Belletrutti, Gina Dimitropoulos, et al.. (2020). Perceived Impacts of the COVID-19 Pandemic on Pediatric Care in Canada: A Roundtable Discussion. Global Pediatric Health. 7. 2333794X20957652–2333794X20957652. 10 indexed citations
8.
Pryzdial, Edward L.G., et al.. (2018). Blood coagulation dissected. Transfusion and Apheresis Science. 57(4). 449–457. 18 indexed citations
10.
Belletrutti, Mark, et al.. (2017). Supplemental Oxygen during Air Travel in Sickle Cell Disease -Common Clinical Practices. Blood. 130. 2079–2079. 1 indexed citations
11.
Nicholas, David, et al.. (2016). Examining the Experiences of Fathers of Children with a Life-Limiting Illness. Journal of Social Work in End-of-Life & Palliative Care. 12(1-2). 126–144. 41 indexed citations
12.
Lehr, Thorsten, Lisa Cronin, Maximilian T. Lobmeyer, et al.. (2016). Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents. Thrombosis and Haemostasis. 116(9). 461–471. 29 indexed citations
13.
Belletrutti, Mark, et al.. (2015). HbM methaemoglobinaemia as a rare case of early neonatal benign cyanosis. BMJ Case Reports. 2015. bcr2015212336–bcr2015212336. 5 indexed citations
14.
Estey, Mathew P., Mark Belletrutti, Karina Rodríguez-Capote, & Trefor Higgins. (2015). Hemoglobin Constant Spring exhibits prolonged ex vivo stability when assessed by HPLC. Clinical Biochemistry. 48(10-11). 709–712. 3 indexed citations
15.
Chellapandian, Deepak, Furqan Shaikh, Cor van den Bos, et al.. (2015). Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study. Pediatric Blood & Cancer. 62(12). 2162–2166. 11 indexed citations
16.
Belletrutti, Mark, David L. Bigam, Ravi Bhargava, & Paul E. Grundy. (2012). Use of Gemcitabine With Multi-stage Surgical Resection as Successful Second-line Treatment of Metastatic Pancreatoblastoma. Journal of Pediatric Hematology/Oncology. 35(1). e7–e10. 6 indexed citations
17.
El‐Matary, Wael, Maryam Soleimani, Donald W. Spady, & Mark Belletrutti. (2010). Typhlitis in Children With Malignancy. Journal of Pediatric Hematology/Oncology. 33(3). e98–e100. 13 indexed citations
18.
Belletrutti, Mark, et al.. (2008). A "living" will. Canadian Medical Association Journal. 178(6). 736–736. 2 indexed citations
19.
Belletrutti, Mark, et al.. (2008). Evaluation of enoxaparin dosing requirements in infants and children. Thrombosis and Haemostasis. 101(1). 86–92. 55 indexed citations
20.
Belletrutti, Mark, Kaiser Ali, Dorothy Barnard, et al.. (2007). Chronic Immune Thrombocytopenic Purpura in Children. Journal of Pediatric Hematology/Oncology. 29(2). 95–100. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026